metastatic breast cancer
Itovebi With Palbociclib and Fulvestrant Approved for Some Advanced Breast Cancer Patients
The FDA has approved inavolisib (Itovebi, Genentech) with palbociclib and fulvestrant for adults with ...
OCTOBER 11, 2024
Trastuzumab Deruxtecan Beats Standard Even in Very Low HER2 Metastatic Breast Cancer
Already approved for HER2-low metastatic breast cancer (MBC) after at least one line of chemotherapy, the ...
AUGUST 7, 2024
Tucatinib Plus T-DM1 Improves PFS in Metastatic Breast Cancer
Adding tucatinib (Tukysa, Seagen) to trastuzumab emtansine (Kadcyla, T-DM1, Genentech) improved progression-free ...
FEBRUARY 19, 2024
FDA Approves Truqap With Fulvestrant for Breast Cancer
The FDA approved capivasertib (Truqap, AstraZeneca) with fulvestrant for adult patients with hormone receptor ...
NOVEMBER 17, 2023
FDA Expands Indications for Verzenio in Patients With Breast Cancer
The FDA has expanded the indications for abemaciclib (Verzenio, Eli Lilly) in early and metastatic breast cancer, ...
MARCH 31, 2023
Orserdu Approved for ER-Positive, HER2-Negative, ESR1-Mutated Advanced or Metastatic Breast Cancer
The FDA has approved elacestrant (Orserdu, Stemline Therapeutics) for postmenopausal women or adult men with ...
FEBRUARY 3, 2023
Scientists Identify Gene Driving Breast Cancer Metastasis
Researchers have pinpointed the gene that’s responsible for metastatic triple-negative breast cancer, ...
MARCH 10, 2022
Neratinib Shows Promise in Certain Metastatic Breast Cancer Cases
A combination of neratinib, fulvestrant and trastuzumab showed encouraging clinical activity in patients with ...
MARCH 9, 2022
Pyrotinib Plus Chemotherapy May Improve Outcomes in Patients With Pretreated HER2-Positive Breast Cancer
Among patients with previously treated HER2-positive metastatic breast cancer, those treated with pyrotinib plus ...
MARCH 9, 2022
Distant Mets Studied by Breast Cancer Subtype
Bone metastases occur more frequently in patients with hormone receptor (HR)-positive/HER2-negative breast cancer ...
JUNE 22, 2017
Patients Flock to Direct-to-Consumer Breast Cancer Project
More than 3,000 women and men with metastatic breast cancer from all 50 states have joined the Metastatic Breast ...
MARCH 2, 2017
Despite Guidelines, Chemo Often Used First-Line for Luminal-Like mBC
Endocrine therapy is recommended as the first-line treatment in luminal-like mBC, but a significant number of ...
FEBRUARY 13, 2017